Impact of Modified Feeding Protocol on Neonatal Outcomes
NCT ID: NCT06246032
Last Updated: 2024-02-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
30 participants
INTERVENTIONAL
2023-05-01
2024-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The main questions it aims to answer are:
* Is Modified feeding protocol will decrease the duration of parenteral nutrition and length of hospital stay?
* Is Modified feeding protocol feasible, efficient, and safe in preterm infants?
Participants will undergo the modified feeding protocol since birth until discharge.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Preterm Neonatal Feeding Protocol Comparing Feed Administration Time
NCT00997854
Comparison of Early Versus Late Trophic Feeding
NCT07229885
Evaluation of a Standard Preterm Infant Formula Fed to Preterm Infants in the Hospital
NCT01766011
Early Versus Delayed Feeding in Preterm Growth-Restricted Infants
NCT03443297
Re-feeding Gastric Residuals in Preterm Infants
NCT01420263
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Both group will have care as routine care to this kind of patients But the differ will be in feeding protocol as initiation rate, advancement rate, human milk fortification rate
The outcomes of both group will be compeered to meet the study objectives
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
SINGLE_GROUP
SUPPORTIVE_CARE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Modified feeding Protocol
Prospective
Modified feeding Protocol
Initiation of feeding (fixed): 10cc/kg
Advancement based on birthweight (fixed):
\<750g: 15cc/kg/d 750-999g: 20cc/kg/d 1000-1249g: 25cc/kg/d 1250-1499g: 25cc/kg/d 1500-1749g: 35cc/kg/d 1750-2000g: 35cc/kg/d
Starting Human milk fortification when feed reach at 70cc/kg/d
Current feeding Protocol
Retrospective data will be collected from medical record of patients undergo the current feeding protocol as follow
Initiation of feeding (average):
8.7cc/kg (6-12cc/kg)
Advancement based on birthweight (average):
\<750g: 20cc/kg/d (17-24cc/kg/d) 750-999g: 29cc/kg/d (25-34cc/kg/d) 1000-1249g: 22cc/kg/d (20-24cc/kg/d) 1250-1499g: 24cc/kg/d (21-25cc/kg/d) 1500-1749g: 20cc/kg/d (18-21cc/kg/d) 1750-2000g: 34cc/kg/d (32-36cc/kg/d)
Starting Human milk fortification when feed reach at 120cc/kg/d
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Modified feeding Protocol
Initiation of feeding (fixed): 10cc/kg
Advancement based on birthweight (fixed):
\<750g: 15cc/kg/d 750-999g: 20cc/kg/d 1000-1249g: 25cc/kg/d 1250-1499g: 25cc/kg/d 1500-1749g: 35cc/kg/d 1750-2000g: 35cc/kg/d
Starting Human milk fortification when feed reach at 70cc/kg/d
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Gestational Age (\<37 week)
Exclusion Criteria
* Congenital Heart Diseases
* Chronic Lung Disease
* Congenital Anomalies (can related to feeding)
* Moderate to severe GERD
* Necrotizing enterocolitis stage 3 (surgical)
* Gastrointestinal surgery
2 Months
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Imam Abdulrahman Bin Faisal University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Hanan AlQahtani
Clinical Dietitian
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Hanan AlQahtani, Master
Role: PRINCIPAL_INVESTIGATOR
Imam Abdulrahman Bin Faisal University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Maternity and Children Hospital
Dammam, Eastern Province, Saudi Arabia
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRB-PGS-2023-03-443
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.